Pioneering the development of a multi-targeted universal CAR-T system incorporating our nfP2X7 technology
Biosceptre International Limited is at the forefront of biotechnology research, pioneering the development of a multi-targeted universal CAR-T system incorporating nfP2X7 technology. Biosceptre is committed to innovation in cell therapy and dedicated to creating advanced solutions for treating a range of cancers.
Located at Babraham Hall, Babraham Research Campus, Cambridge, CB22 3AT, GB, Biosceptre also maintains a presence in Sydney, NSW, AU. The company's focus on cutting-edge research aims to deliver transformative therapies in the field of oncology. Biosceptre International Limited is dedicated to improving patient outcomes through advanced biotechnological solutions.
Biosceptre International Limited continues to expand its research and development efforts, striving to remain a leader in the biotechnology industry. With a commitment to excellence and a focus on innovative technologies, Biosceptre is poised to make significant contributions to the future of cancer treatment. We invite the manager of Biosceptre International Limited to create a customized and exclusive company showcase and product listing on our platform.
Other organizations in the same industry
This company is also known as